SCHEMBL10189183

SCHEMBL10189183

C1=Cc2cn[nH]c2CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28051130 0.72 SLC2A1 (0.33)
SCHEMBL22203157 0.68 NOS3 (0.31)
SCHEMBL1141780 0.65
SCHEMBL10292283 0.62
SCHEMBL12802013 0.61
SCHEMBL16572043 0.61
SCHEMBL14731219 0.60
SCHEMBL11977450 0.59
SCHEMBL13185718 0.58 KDM4E (0.33)
SCHEMBL789743 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110256462-A Spiral shell [indazole-isoxazole] derivative and preparation method of p-fluorophenyl substitution structure containing chromone and application 绍兴文理学院 2019-09-20 CN claimed
CN-110156812-A Spiral shell [indazole-isoxazole] derivative and preparation method of the structure containing chromone and application 绍兴文理学院 2019-08-23 CN claimed
CN-110128445-A Spiral shell [indazole-isoxazole] derivative and preparation method of rubigan substitution structure containing chromone and application 绍兴文理学院 2019-08-16 CN claimed
CN-110128446-A 3,4, 5-trimethoxy phenyl substituted spiro [ indazole-isoxazole ] derivative containing chromone structure, and preparation method and application thereof 绍兴文理学院 2019-08-16 CN disclosed
CN-108349947-A Tetrahydrochysene indazole and its medical usage S·莱恩 2018-07-31 CN disclosed
EP-2323993-B1 2,6-DIAMINO- PYRIMIDIN- 5-YL-CARBOXAMIDES AS SYK OR JAK KINASES INHIBITORS PORTOLA PHARM INC (US) 2015-06-03 EP disclosed
EP-2067743-B1 Process for preparation of surface modified silicon nanoparticles EVONIK DEGUSSA GMBH (DE) 2013-07-10 EP disclosed
US-20120059012-A1 3-(4-AMINOPHENYL)-2-FURANCARBOXYLIC ACID DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2012-03-08 US disclosed